Risk of acute coronary syndrome and peripheral arterial disease in chronic liver disease and cirrhosis: A nationwide population-based study

2018 ◽  
Vol 270 ◽  
pp. 154-159 ◽  
Author(s):  
Shih-Yi Lin ◽  
Cheng-Li Lin ◽  
Cheng-Chieh Lin ◽  
I-Kuan Wang ◽  
Wu-Huei Hsu ◽  
...  
2020 ◽  
Vol 41 (1) ◽  
pp. 61-67
Author(s):  
Tolga Vural ◽  
Makbule Neslişah Tan ◽  
Mehtap Kartal ◽  
Azize Dilek Güldal

2013 ◽  
Vol 57 (5) ◽  
pp. 67S-68S
Author(s):  
Jeff Nienaber ◽  
Manju Kalra ◽  
Mateus P. Correa ◽  
Jennifer St. Sauver ◽  
Carin Smith ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-8 ◽  
Author(s):  
Hassan A. Al-Thani ◽  
Ayman El-Menyar ◽  
Mohammad Zubaid ◽  
Wafa A. Rashed ◽  
Mustafa Ridha ◽  
...  

To describe prevalence and impact of peripheral arterial disease (PAD) in patients with acute coronary syndrome (ACS), data were collected over 5 months from 6 Middle Eastern countries. Patients were divided into 2 groups (with and without PAD). Out of 6705 consecutive ACS patients, PAD was reported in 177 patients. In comparison to non-PAD, PAD patients were older and more likely to have cardiovascular risk factors. They were more likely to have high Killip class, high GRACE risk score, and non-ST elevation ACS (NSTEACS) at presentation. Thrombolytics, antiplatelet use, and coronary intervention were comparable in both groups. When presented with ST-elevation myocardial infarction (STEMI), patients with PAD had worse outcomes, while in NSTEACS; PAD was associated with higher rate of heart failure in comparison to non-PAD patients. In diabetics, PAD was associated with 2-fold increase in mortality when compared to non-PAD (P=0.028). After adjustment, PAD was associated with high mortality in STEMI (adjusted OR 2.6; 95% CI 1.23–5.65,P=0.01). Prevalence of PAD in ACS in the Gulf region is low. Patients with PAD and ACS constitute a high risk group and require more attention. PAD in patients with STEMI is an independent predictor of in-hospital death.


Sign in / Sign up

Export Citation Format

Share Document